explore -WSS

explore

author：Wikipedia 2025-09-29 13:09:44 - browse：959

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Kaiser's Risant Health gobbled up Geisinger. Who is next?

Wikipedia

WSS

At ASCO, AstraZeneca reports strong data for breast cancer drug

Let's speed up science by embracing open access publishing

Let's speed up science by embracing open access publishing

New details revealed about Purdue's marketing of OxyContin

Listen: Racing for gene therapy & a pioneering approval

Cord blood banking comes at a high cost to babies

focus

explore

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Jerome Adams on the need for new antivirals for Covid

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

ChatGPT in medicine: STAT answers readers' burning questions

Listen: Racing for gene therapy & a pioneering approval

Duchenne breakthrough therapy leaves behind pioneering families

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

New air purifier tech could be key to improving indoor air quality

An interview with Robert F. Kennedy Jr. on vaccines

hotspot

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Patient advocates sound warning on FDA proposal on salt intake

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Patient advocates sound warning on FDA proposal on salt intake

ASCO: AstraZeneca says CAR

Baltimore teen accused of firing into crowd during block party mass shooting

Wikipedia

focus

Wikipedia

explore